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ABSTRACT
The exploration of biomolecular motors in nanotechnological applications has generated much
interest in the scientific community. Although the recent progress has been very promising,
several requirements have yet to be fulfilled in order for motor proteins to be useful in
nanotechnological applications. Here, we present a simple method for patterning myosin II on
a microstructured surface. Our findings indicate that UV/ozone treatment can be used to alter
the hydrophobicity of trimethyl-chloro-silane (TMCS) coated glass surfaces, to alter protein
binding, and effectively produce localized motor activity. Taken together, these data suggest
that photoreactive patterning may be useful for the selective localization of functional myosin
II motor tracks.
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CHAPTER 1

INTRODUCTION
Nanobiotechnology is defined as a field that applies nanoscale principles and techniques
to understand and transform biosystems

(1)

. One aspect of nanobiotechnology is the study of

bionanomotors. Bionanomotors are amazing biological machines that are responsible for most
forms of movement we encounter in the cellular world. These biomolecular motors convert
chemical energy form adenosine triphosphate (ATP) into mechanical work

(2)

. Three types of

cytoplasmic motors are known- the myosins, which move on actin filaments, the dyneins and the
kinesins, which use microtubules as tracks. Bionanomotors are ubiquitous nanoactuators that
convert chemical energy into mechanical work through ATP hydrolysis (3). The myosin motor is
involved in muscle contraction, cytokinesis, cell movement, membrane transport, cell
architecture, and certain signal transduction pathways

(4)

. The use of molecular motors for

nanotechnological applications may be desirable when compared to other technologies such as
micro fluidics which is the “current state of the art”. Possible advantages include minimal
dependency of transportation velocity on channel geometry and the fact that bidirectional
transportation is made possible. In addition, the motors offer the unique potential to position
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individual molecules at a certain point in space (5). Although highly promising, the use of myosin
or other bionanomotors for nanotechnological applications has been hampered due to limitations
in the ability to accurately control the motion of the moving filaments as they travel across the
substrate surface. Given this restraint, several approaches have been developed and utilized over
the past few years to create well defined patterns of motor proteins across a micro patterned
surface. For example, motor protein binding tracks have been produced by aligned
poly(tetrafluoroethylene) films on glass, micrometer scale grooves, and nanoimprinting
lithography (for review please refer to

(6, 7)

). However, in most cases, the motility is not entirely

confined to the tracks. Recently, Sundberg and colleagues demonstrated that trimethyl chloro
silane (TMCS) is capable of supporting myosin II motor activity and that electron beam
lithography could be used to confine the motility of myosin II propelled actin filaments

(5, 8)

. In

addition, their data also suggests that TMCS may offer several advantages over nitrocellulose for
the performance of the in vitro motility assay. Here we attempt to expand upon their work by
examining the utility of ultraviolet (UV) light in the presence of atmospheric oxygen, which is
readily converted to ozone in the presence of UV, to produce spatially localized patterning of
active myosin II motors on a TMCS coated substrate.
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PURPOSE
Our long term goal is to develop the means of utilizing bionanomotors for nanotechnological
applications. The purpose of this study is to investigate if UV/Ozone can be used to pattern
active myosin motors on a TMCS coated surface.

SPECIFIC AIMS
The central hypothesis of this study is that UV/Ozone can be used to pattern
bionanomotors on a TMCS coated surfaces. To test this hypothesis two specific aims will be
pursued.

Specific Aim #1
To determine if UV/Ozone can be used to pattern proteins on a TMCS coated surface.
Hypothesis: UV/Ozone treatment can be used to produce spatially localized patterning of
proteins on a TMCS coated substrate.

Specific Aim #2
To determine if UV/Ozone can be used to pattern functional myosin molecules on a TMCS
coated surface.
Hypothesis: UV/Ozone treatment can be used to produce spatially localized patterning of
active myosin motors on a TMCS coated substrate.
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CHAPTER 2

Review of the Literature

INTRODUCTION
A review of the pertinent literature concerning the present study will be presented in the
following chapter.

The following areas will be addressed:

1) Nanobiotechnology and

applications in nanomedicine, 2) Structure and function of molecular motor proteins, and 3)
TMCS – substrate and its transformation for in vitro applications

Nanobiotechnology and applications in Nanomedicine:
Nanoscience is the study of phenomena and manipulation of materials at atomic,
molecular levels

(1)

. It is thought that nanoscience exhibits a tremendous amount of potential in

several different areas of science such as medicine, water decontamination, communication
technologies, agriculture, and aerospace engineering

(9)

. Potential applications in nanomedicine

include intelligent drug delivery, the use of nanoparticles to improve bioavailability or the
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pharmacokinetic profile of therapeutics

(10)

. Examples of different strategies include the use of

dendrimers, leptosomes and polymer therapeutics. In addition, it is also possible that
nanoparticles could be used as contrast agents to improve in vivo imaging

(11)

. For example,

super paramagnetic iron oxide nanoparticles have recently been used to improve the resolution of
MRI testing. Further, novel nano sensors have also been used to amplify the sensitivity of in
vitro diagnostics tests. For example, Nanomix (Emeryville, CA, USA) has developed carbon
nanotube based sensors for monitoring respiratory function. Similarly, Virichip (Ames, IA,
USA).

Structure and function of molecular motor proteins:
Molecular motors are motor proteins which convert the chemical energy of ATP
hydrolysis to mechanical energy

(12)

. There are three different families of molecular motors:

myosin, kinesin and dynein. In the cytoskeletal system, molecular motors perform directed
motion along filamental tracks. Myosin uses tracks of actin filaments, while dynein and kinesin
utilize microtubules.
Myosins are molecular motors that diversified very early during eukaryotic evolution

(13,

14)

. Most eukaryotes rely on myosins, and only a few taxonomic groups, e.g., red algae and

diplomonad protists appear to live without them (15). Myosin heavy chains have been categorized
into 18 classes, mostly based on comparisons and phylogenetic analysis of the conserved motor
domain (16) .
Myosin II is well known motor protein of myosin family, present in all non-plant
eukaryotic cells (17). It performs several different tasks such as muscular contraction, cytokinesis,
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membrane and vesicle transport (14). Myosin II consists of two heavy chains and four light chains.
The light chains are divided into essential and regulatory chains. The light chains in addition to
regulatory roles, help to stabilize the neck region.

Figure 1. Myosin II showing the heavy chain consists of head, neck and tail regions, essential and regulatory
light chains.

The myosin head is an actin-activated adenosine triphosphatase (ATPase)

(18)

. The

movement of myosin II like that of other motor proteins are carried out through a swinging of the
lever arm. Transduction of the energy released by ATP hydrolysis into directed mechanical force
occurs during product release - adenosine diphosphate (ADP) and inorganic phosphate, [Pi] rather than during the hydrolysis step itself

(18)

.

9

Myosin II can be proteolitically cleaved with a protease, ά-chymotrypsin, into two stable
fragments, one of which includes the motor domain and is called heavy-meromyosin (HMM),
while the other fragment carrying the tail domain, is called light-meromyosin (LMM). The motor
domain of HMM contains the ATPase activity of the parent myosin (19).

Adopted from (http://www.biomed.miami.edu/pharm/faculty_Szczesna.html)

Figure 2. Myosin head showing the actin and ATP binding sites.
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Actin is a very common structural component of the human body. The muscle fibers and
much of the cytoskeleton is composed of actin

(20)

. F-actin or filamental actin is a two-stranded

helical polymer in which each strand has a structural polarity. The monomers that make up the Factin strand are called G-actin or globular actin. The polarity of the actin polymers gives the
motors proteins that move along them a directional preference (17).

Figure 3. Three dimensional structure of actin.
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The myosin-actin system has specific advantages such as a higher velocity of movement
and higher force production, which would permit a more rapid transduction and higher transport
capacity for dynamic nanodevices

(21)

. Nonetheless, the loss of the ordered arrangement of the

contractile proteins in vitro may affect important aspects of normal actomyosin function

(22)

. In

order for this normal actomyosin function it is reasonable to presume that the interactions require
an ordered arrangement of the contractile proteins similar to that existing in a muscle fiber.
Furthermore, the reconstruction of an ordered actomyosin system in vitro may also be of
considerable value for nanotechnological applications

(6)

. Efforts to reconstruct the ordered

assembly of the muscle sarcomere ex vivo have thus far been unsuccessful.

TMCS – substrate and its transformation for in vitro applications:
One way to establish motor protein order in vitro, may be to use micro structuring
techniques to produce motor protein binding tracks in different polymer materials

(23)

. Bunk et.,

al., (2003) made progress with creating a myosin binding polymer tracks using the electron beam
lithography

(6)

and nanoimprinting lithography. By manipulating these techniques Sundberg et

al., (2006) succeeded in producing narrow tracks (<200nm) for adsorption of heavy meromyosin
(24)

.

Nonetheless, one drawback of the polymer resist was that the velocity of movement was
about 20-30% lower than that observed on nitrocellulose coated surfaces

(6)

. This suggests that,

while the resist system may be used for nanotechnology applications that it may not be ideal for
optimal performance. Silanized surfaces have been used in nanotechnology to create laterally
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defined functional structures. Organosilane monolayers, such as TMCS, form on silicon oxide
surfaces by reacting with silanol groups to form Si-O-Si bonds

(25)

. Furthermore, some silanized

surfaces have previously been shown to support actomyosin motility in the in vitro motility assay
(26)

. Experiments conducted by Sundberg et.,al 2003, suggests that TMCS is superior to other

silanes, with respect to supporting myosin activity. Furthermore the fraction of moving filaments
on myosin adsorbed to TMCS-treated surfaces (with covalently bound trimethylsilyl groups) was
higher than those on nitrocellulose. Additional characterization of such surfaces suggests that
they have other advantages over nitrocellulose in the conventional in vitro motility assay and
over resist polymers in nanostructured in vitro motility assays (8).

Experiments in the laboratories of Koberstein

(27)

and Genzer

(28)

showed that

polydimethyl siloxanes (an analogue to the TMCS surface) treated with UV/Ozone formed a
silica-like, hard film on the polymer surface. It was speculated in their experiments that the
active oxygen species react with the methyl groups to form oxidized organic moieties. After
extended exposure in the UV/Ozone environment, the oxidizing atmosphere eventually led to the
removal of volatile compounds such as carbon dioxide and other small organic molecules
leaving behind the less volatile silica species. Whether such surfaces support myosin activity or
filament mobility has not been examined.
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Summary
Trimethyl cholorosilane (TMCS) forms a suitable substrate for conventional in vitro
motility assays and supports actomyosin motility as good or superior to that observed for
nitrocellulose and polymer resists. TMCS may be amendable for nanodevice manufacturing due
to its chemical transition properties, to our knowledge UV/Ozone can be used to pattern myosin
on TMCS substrate.
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CHAPTER 3

Assembly and Function of Myosin II on Ultraviolet/Ozone Patterned
Trimethylchlorosilane Substrates.*

*This manuscript has recently been accepted to the Journal of Bionanoscience
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ABSTRACT
The study of biomolecular motors represents a rapidly and progressing field of
nanobiotechnology. Here, we present a simple method for patterning myosin II on a
microstructured surface. Our findings indicate that UV/ozone treatment can be used to alter the
hydrophobicity of trimethyl-chloro-silane (TMCS) coated glass surfaces, to alter protein binding,
and effectively produce localized motor activity. Taken together, these data suggest that
photoreactive patterning may be useful for the selective localization of functional myosin II
motor tracks.
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1. INTODUCTION
Biological motors convert chemical energy to effect stepwise linear or rotary motion, and
are essential in controlling and performing a wide variety of biological functions

(7)

. Linear

motor proteins are central to many biological processes including muscle contraction and
intracellular transport. For example, eukaryotic cells use molecular motors (e.g., kinesin and
dynein) to transport large molecules that do not diffuse well and to transport other large cell
structures such as organelles and vesicles. Biological motors, because of their high efficiency
and very small scale, have prompted an increasing number of studies focused on the integration
of biological motors in hybrid microdevice and nanodevice. Compared to existing micro fluidic
transport systems the use of motor proteins may be beneficial because of their ability to transport
individual molecules in the absence of bulk flow. In addition, biological motors use ATP only at
the site of action thereby allowing this mode of transport to operate in the absence of external
power or bulky pumps (29).
In recent years the development of biomolecular motors towards the construction of
actuators and transporters has seen tremendous progress with recent studies demonstrating the
potential of biological motors to transport micrometer and nanometer-sized objects (30). The most
common experimental technique used to investigate the use of biological motors is the in vitro
motility assay. In this assay, motors are adsorbed to surfaces through their tail domain and
microtubules or actin filaments, which can be functionalized with cargo such as biomolecules or
nanoparticles, are propelled along the surface by the functional motor heads

(31)

. Although very

useful for the study of biomotor function, the application of biomolecular motors for
nanotechnological applications has been hampered by limitations in the ability to accurately
control the motion of the moving filaments as they travel across the substrate surface. Given this
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restraint, several approaches have been developed and utilized over the past few years to create
well defined patterns of motor proteins across a micro patterned surface. For example, motor
protein binding tracks have been produced by aligned poly(tetrafluoroethylene) films on glass,
micrometer scale grooves, and nanoimprinting lithography (for review please refer to

(6, 7)

).

However, in most cases, the motility is not entirely confined to the tracks. Recently, Sundberg
and colleagues demonstrated that trimethyl chloro silane (TMCS) is capable of supporting
myosin II motor activity and that electron beam lithography could be used to confine the motility
of myosin II propelled actin filaments

(5, 8)

. In addition, their data also suggests that TMCS may

offer several advantages over nitrocellulose for the performance of the in vitro motility assay.
Here we attempt to expand upon their work by examining the utility of ultraviolet (UV) light in
the presence of atmospheric oxygen, which is readily converted to ozone in the presence of UV,
to produce spatially localized patterning of active myosin II motors on a TMCS coated substrate.
Our findings indicate that UV/ozone treatment can be used to alter the hydrophobicity of the
TMCS surface, to modify protein binding to the TMCS treated region and to effectively produce
localized motor activity. Taken together, these data suggest that photoreactive patterning may be
a convenient method to produce functional myosin II motor tracks for the directed motility of
actin filaments.

2. EXPERIMENTAL DETAILS
Surface preparation.
Glass cover slips (Cat. No. 12-540A, Fisher) were functionalized with nitrocellulose (2%
collodion in isoamyl acetate, Okenshoji Co, Japan) using solution deposition and soft-baking at
40ºC for 1 hr as detailed previously (31). Or TMCS (trimethyl-chloro-silane, Sigma Aldrich) was
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applied using chemical vapor deposition by placing coverslips in a chamber containing a TMCSsaturated atmosphere for 10 min at room temperature

(24)

. In experiments that used UV/ozone

treatment, TMCS coated coverslips were exposed to UV light (UVL 20 US-60; 4.5 W; 275 nm;
50 μW/cm2, Sen lights Co., Osaka, Japan) in the presence of atmospheric oxygen for different
time points as indicated in the text.

Contact angle measurements.
The hydrophobicity of TMCS coated cover slips and TMCS-UV/ozone treated cover
slips was determined by water contact angle measurements. Contact angles were measured on
sessile drops (2μL) of Nanopure water at room temperature (20-23°C) in air using a contact
angle goniometer constructed from an XY stage fitted with a 20 X lens system and a fiber-optic
illuminator. The images were captured using a digital camera (Leica DFC280, Germany) and
analyzed using the low bond axisymmetric drop shape analysis subroutine in Image J
(http://rsb.info.nih.gov/ij/, http://bigwww.epfl.ch/demo/dropanalysis/). Observed values were
averaged over six different readings.

Protein binding to UV/Ozone-treated TMCS surfaces.
TMCS coated cover slips were treated with UV/Ozone for varying time periods (0, 0.5, 1,
2, 5, or 10 min) and then used in the construction of flow cells using strips of double sided 90
µm thick tape (Nichiban Co, Japan). The resulting chambers had dimensions of approximately 6
mm by 90 µm in cross section. Once assembled, chambers were incubated with BSA-FITC
(Bovine Serum Albumin-Fluorescein Isothiocyanate, Molecular Probes, Inc, OR) (5µg/ml) for
30 min at room temperature (20-23°C), and then washed three times with motility buffer (25 mM
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KCl, 2mM MgCl2, 0.2mM CaCl2, 25mM Imidazole). The sample was observed with an Olympus
fluorescence microscope (Olympus America, USA) fitted with a 100X objective and chargecoupled device (CCD) camera. Images were collected using imaging software (Olympus
MicroSuite Basic, Olympus America, USA) using the same exposure period and camera control
settings throughout.

HMM ATPase activity on UV/Ozone-treated TMCS surfaces.
Glass coverslips were incubated with heavy meromyosin (HMM) (48 µg/ml) solubilized
in K/EDTA ATPase buffer (0.5 M KCl, 5 mM EDTA, 20 mM Tris HCl (pH7.5)) for 10 min on
ice and then blocked with 1 mg/ml BSA for 10 min. Once coated, coverslips were incubated with
1.6 ml of K/EDTA ATPase buffer supplemented with 0.5 mM ATP for 30 min at 25 ºC. ATP
(adenosine-5`-triphosate) hydrolysis by the HMM was determined by measuring the absorbance
of aliquots for the presence of inorganic phosphate (Pi) using the malachite green method

(32)

.

The number of ATPase-active HMM molecules per unit area were estimated by comparing the
ATPase rate to that of a known concentration of HMM in solution.

Protein patterning with UV/Ozone on TMCS substrates.
To examine the potential of UV/Ozone exposure to pattern fine lines an electron
microscope grid (Electron Microscopy Sciences, PA, USA) was placed on a quartz slide (SPI
supplies, PA, USA) that was in turn mounted over a TMCS coated coverslip. Once assembled,
the cover slip was then placed ~1 cm under the UV light for 10min. Using a flow cell, BSAFITC (5µg/ml) was applied to the surface and the solution allowed to incubate for 30 minutes at
room temperature (20-23°C). Excess, unbound BSA-FITC was removed by rinsing the flow cell
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three times with 50 µl of motility buffer. Protein patterning was observed using by
epifluorescence using an Olympus fluorescence microscope (Melville, NY, USA) fitted with a
×40 objective.

Motility assays.
The procedures of the motility assay have been described previously

(31)

. Briefly, HMM

was extracted from the back and leg muscle of a rabbit and purified as described elsewhere
HMM was prepared by limited digestion of myosin with α-chymotrypsin

(33)

.

(31)

. Actin was

extracted in the monomeric form from an actin acetone powder of chicken breast muscle

(34)

and

then the polymerized actin filaments were labeled with tetramethylrhodamine-phalloidin
(Molecular Pobes, Inc., OR, USA). Flow cells were constructed from a No. 2 cover slip using
strips of double sided 90 µm thick tape (Nichiban Co, Japan). The flow cell was filled with 60,
90, or 120 µg/ml HMM diluted in the assay buffer which contained 25 mM KCl, 2 mM MgCl 2,
0.2 mM CaCl2 and 25 mM imidazole at pH 7.0 and incubate for 5 min. Bovine serum albumin
(0.1 % BSA in water) was used to prevent the filaments from nonspecifically binding to the
surface. After a 5 min incubation, the flow cell was washed with the assay buffer, and 0.25 µg/ml
labeled filaments in assay buffer supplemented with 10 mM dithiothreitol, 4.5 mg/ml D(+)glucose, 0.22 mg/ml glucose oxidase and 0.036 mg/ml catalase was introduced into the flow cell.
Motility was activated by exchange of actin loading solution with assay buffer containing 1.5mM
adenosine-5`-triphosate (ATP). Motility assays were performed at room temperature (20-23°C)
and observed under fluorescence microscope (Olympus BH-2, Japan) with a 100X objective (1.3
N.A., oil-immersion; UVFL100, Olympus, Japan) through a CCD camera (Hamamatsu
Photonics C2400, Japan) and a monitor. The images of the filaments were digitally recorded onto
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a computer (Dell, Dimension 4300). The velocity of actin filament movement was analyzed
using software (Image J) as outlined by the manufacturer (http://rsb.info.nih.gov/ij/). Image
frames were collected at 0.5 Hz for 30 s. The sliding of all filaments in the images was obtained
by tracking the leading end of each filament in each frame.

Statistical analysis.
Results are presented as mean ± SEM. All comparisons were performed by Students ttests or a two-way analysis of variance (ANOVA) with post hoc analysis where appropriate. For
all comparisons the alpha level was set a priori at P≤ 0.05.

3. RESULTS AND DISCUSSION
Surface hydrophobicity with UV/Ozone exposure.
The ability to pattern molecular motors onto a surface would increase the use of these
molecules for nanotechnological applications. TMCS has recently been shown to support myosin
II mediated F-actin motility

(5, 24)

. Organosilane monolayers, such as TMCS, form on silicon

oxide surfaces by reacting with silanol groups to form Si-O-Si bonds (25) (Figure 4). Experiments
in the laboratories of Koberstein

(27)

and Genzer

(28)

showed that polydimethyl siloxanes (an

analogue to the TMCS surface) treated with UV/Ozone formed a silica-like, hard film on the
polymer surface. It was speculated in their experiments that the active oxygen species react with
the methyl groups to form oxidized organic moieties. After extended exposure in the UV/Ozone
environment, the oxidizing atmosphere eventually led to the removal of volatile compounds such
as carbon dioxide and other small organic molecules leaving behind the less volatile silica
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species. We have also used UV/Ozone to modify the functional groups at the interface of our
substrates. We presume that the TMCS surfaces will undergo a similar type of transition as the
PDMS surfaces under the oxidizing conditions in our experiments; namely, a transition from
methyl groups to a combination of methyl and oxidized carbon groups (e.g. hydroxides or
carboxylates) and eventually into a silica-like surface. To examine the relationship between
UV/ozone treatment and TMCS surface chemistry we estimated the hydrophobicity of treated
surfaces by determining water contact angles. With increasing UV/Ozone treatment, the water
contact angle decreased as expected for the exchange of surface methyl groups for oxidized
organic species (Figure 5). These results indicate that UV/Ozone treatment of TMCS surfaces is
effective in enhancing surface hydrophilicity.

Protein binding to TMCS following UV treatment.
To determine how UV/Ozone treatment affects protein binding to TMCS coated surfaces,
FITC labeled BSA was allowed to bind to TMCS coated cover slips that had undergone
UV/Ozone treatment. Binding affinity was estimated indirectly by digitizing the captured images
and then determining the average pixel intensity of twelve randomly positioned regions (2,500
µm2) per flow cell. To allow approximate quantitative comparisons, all imaging parameters
(pixel dwell time, optical and electronic filters, and detector gain and offset) were kept constant
between samples.
Figure 6 shows fluorescent intensities of square areas covering the TMCS coated surface.
As UV/Ozone treatment is increased, the binding of the FITC labeled BSA to the TMCS surface
is decreased. In a study by Whitesides et al.

(35)

, the authors examined a wide array of surface

functional groups to ascertain what makes good protein resistance from solution phase
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deposition. One of the key components of their work that is similar to ours is that hydrophobic
surfaces readily adsorb proteins compared to hydrophilic surfaces. Although we do not know the
chemical make-up of our surface at any point during the UV/Ozone treatment, the water contact
angle data shows that we move from a hydrophobic to a hydrophilic surface. These data show
that UV/Ozone treatment can be used to alter the affinity of TMCS for protein. The exact nature
of this relationship is unclear as many factors may influence protein binding including protein
three-dimensional structure, electrostatic force properties and reactive functional groups on the
protein surface (36, 37).

Protein patterning.
Control over the patterning of biomolecules on solid surfaces, while preventing
nonspecific binding of unwanted areas and species, is an important design consideration for the
development of nanotechnological devices. To examine the potential of UV/Ozone treatment to
produce protein patterning a grating was used to mask the TMCS coated surface. To ensure that
any protein patterning that resulted from this procedure was due to the UV/Ozone exposure and
not due to physical modification or contact, a quartz slide was placed between the grid and the
TMCS coated surface. A fluorescent image of the protein patterning acquired with this technique
is shown in Figure 7. These experiments suggest that UV/Ozone exposure can be used to
effectively prevent non-specific protein binding to a TMCS coated surface.

HMM binding to TMCS with UV/Ozone treatment.
The above results suggest that UV/ozone treatment can be used to control the deposition
of proteins onto a TMCS substrate. To explore the potential of using this approach in patterning
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myosin II we determined how UV/Ozone treatment affected myosin II binding to TMCS by
examining myosin ATPase activity directly on untreated and treated TMCS surfaces. Compared
to glass we observed higher active HMM binding to nitrocellulose and TMCS (glass: 827 ± 188;
nitrocellulose: 1,280 ± 179; TMCS 1,354 ± 146 molecules active HMM / µm2; (P < 0.05),
Figure 8). This finding agrees well with previous data demonstrating that untreated glass is a
poor substrate for supporting actomyosin motility

(24)

. As expected, UV/Ozone treatment

produced a significant decrease in active HMM binding to TMCS (TMCS 1,354 ± 146 vs.
UV/Ozone treated TMCS 372 ± 25 molecules active HMM / µm2; (P < 0.05)).

Actin motility.
Previous reports have demonstrated that actomyosin motility is of similar quality on
chemical vapor-deposited TMCS as on nitrocellulose

(5, 24)

. This finding is important as TMCS

substrates are thought to demonstrate a longer shelf life (8): in our experiments the 3-weeks old
TMCS coated coveslips have similar actomyosin motility to the 2-days old fresh TMCS
coverslips (data not shown), while they also exhibit an increased ability for nanostructuring. We
attempted to extend these observations by examining the motility characteristics of actin
filaments over several different concentrations of myosin. To ensure the ability to compare
across substrates (nitrocellulose, TMCS) all motility assays were performed under identical
conditions. Once introduced into the flow cell, the F-actin was found to bind rigidly to the
myosin immobilized on the cover slip. On the addition of ATP, the actin moved in a continuous
fashion with a velocity in the range of 1.1-1.6 µm/s at 20-23°C of room temperature (Figure 9).
Both nitrocellulose and TMCS appeared to support actin filament motility of each quality and no
differences in velocity of movement were noted when comparing across substrates. As expected,
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the velocity of actin filament movement increased with increasing myosin concentration

(24)

although the values of velocity were not comparable to those in the previous report at 29-32°C
since the velocity depends on temperature and buffer conditions. Taken together these data
support previous reports examining actin-filament motility on TMCS and act to confirm the
suggestion that both TMCS and nitrocellulose support actin filament motility of comparable
quality.
The data presented to this point suggest that UV/ozone treatment can be used to alter
TMCS hydrophobicity, the affinity of TMCS to bind protein, and to pattern protein binding to
TMCS with micrometer resolution. In addition, our motility work suggests that TMCS is capable
of binding myosin II and that this binding is compatible with supporting myosin ATPase activity.
To extend these findings we next tested whether UV/ozone treatment could be used to pattern
TMCS coated surfaces and place active myosin II at discrete locations. For these experiments,
(one half of a TMCS coated cover slip was UV/ozone treated for 5 minutes while the other side
remained unexposed) The desired areas of TMCS coated cover slip were treated for 10 min with
UV/Ozone while the other micro-scaled areas remained unexposed through micelectron
microscopic grid as photomask (Figure 10). Once treated, the effect of UV/Ozone treatment of
TMCS surface on actin filament motility was then determined using the motility assay. As
expected, we observed predominant actin filament motility only on those areas which had not
received UV exposure (Figure 11). Taken together, these data suggest that UV/ozone-treatment
can be used to pattern active biomolecular motors to defined locations across a micropatterned
surface. Or at least reduces the number of HMM proteins adsorbed to the surface to an extent
that limits both F-actin binding and motility.
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Conclusions.
In this paper we present our recent research concerning the use of UV/Ozone treatment to
alter the surface properties of TMCS. We demonstrate that UV/Ozone treatment can be used for
the micropatterning of proteins and biomolecular motors onto a glass substrate. Unlike
conventional photolithographic processing which are oftentimes incompatible with the presence
of biomolecules this technique appears to be well suited for patterning proteins and enzymes.
This method has several attractive points: (1) UV/Ozone treatment does not require expensive
equipment and operates in parallel fashion, (2) although only tested on glass substrates, this
method can be applied to various substrates including silicon, gold and polymer, (3) this method
can be regio-selectively used to pattern biomolecules without spotting or using a dispensing
machine and have flexibility in pattern shape and size, (4) efficiency of protein binding can be
altered by adjusting the UV/ozone treatment conditions, (5) this method can be interfaced with a
robotic spotting machine, piezoelectric, electrospray or inkjet dispenser system to immobilize
many different biomolecules on defined patterns, and (6) the simple, reliable fabrication method
is desirable for mass production. Future research examining the unique properties of TMCS for
nanotechnological applications will no doubt add new uses for this substrate.
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Figures :

Figure 4. Panel A: Schematic depicting mechanism of TMCS binding to glass. Panel B: Surface modification
following UV/ozone treatment.
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.

Figure 5. Depicts the water contact angle on UV/ozone treated TMCS glass as a function of time. Lower
pictures are representative snapshots of the water droplet on the UV/ozone treated surface.
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Figure 6. The relationship between fluorescence intensity and UV/ozone treatment time on BSA-FITC
binding to TMCS surface. Lower picture are representative images of the fluorescence observed on the
UV/ozone treated surface.
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Figure 7.Flourescent image of protein patterning displayed through BSA-FITC absorption on TMCS coated
cover glass following UV/ozone patterning. Upper and lower histograms are cross-sectional profiles at the
indicated lines.
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Figure 8.Substrate binding of HMM on various surfaces as estimated by K/EDTA ATPase assay.
* Denotes statistical significant between the compared conditions. (P<0.05)
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Figure 9.Velocity of F-actin (µm/sec) over nitrocellulose and TMCS coated surfaces at various HMM (60,
90,120 µg/ml) concentrations. Scale bar denotes 5 µm.
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Figure 10. Effect of 5 min UV/ozone treatment on F-actin motility. Image represents the sum of 40
background-subtracted images which represents a 20 sec recording of actin motility at a frame rate of 500ms.
UV/ozone treatment of TMCS vapor deposition surface results in no F-actin motility. Scale bar denotes 10
µm.
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Figure 11. Effect of 5 min UV/ozone patterning on F-actin motility. Images represent a 5 second snapshot at 1
second intervals of motility and the sum of 18 seconds of background-subtracted images. UV/ozone treatment
of TMCS vapor deposition surface results in no F-actin motility. Scale bar denotes 20 µm.
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CHAPTER 4

Conclusions
1. UV/Ozone treatment can be used to produce spatially localized patterning of proteins on
a TMCS coated substrate.

2. Myosin motors can be confined and micro patterned on a TMCS substrate by treatment
with UV/Ozone.

3. TMCS micro-patterning of biolmolecular proteins may be useful for the preparation of
novel nanodevices.

Future directions
The long term goal of this project is to develop the means of utilizing bionanomotors for
nanotechnological applications. Future directions for research based on this study should focus
on the following areas of study.
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1. TMCS coating of other substrates: Future research examining whether other substrates
e.g. PDMS, might be compatible with TMCS would allow the incorporation of
microfluidic systems.

2. Development of the means to load and unload cargo on to the actin filaments: Future
research designed to determine if cargo could be attached to the actin filaments would be
very useful for increasing the utility the myosin motor system for nanotechnological
applications.
3. Development of motor control systems: Future research could be centered on devising
control systems that could be used to regulate myosin enzyme activity. The development
of such systems would permit an increased ability to use myosin based systems for
performing useful activities.
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APPENDIX
Standard in vitro motility assay :
Nitrocellulose coated cover glass:
0.2% Collodion in Isoamyl acetate
Assay buffer: 25mM KCl, 2mM MgCl2, 0.2mM CaCl2, and 25mM Imidazole, pH 7.0
BSA: 1mg/ml
HMM: 60~180µg/ml
Actin solution(X100):
95µL Assay buffer
1µL 1mM DTT
1µL 0.216mg/ml Glucose oxidase,
1µL 0.036mg/ml Catalase
1µL 4.5mg/ml Glucose
1µL 0.25ug/ml RP-labeled F-actin
ATP solution(X100):
95µL Assay buffer
1µL 1mM DTT
1µL 0.216mg/ml Glucose oxidase,
1µL 0.036mg/ml Catalase
1µL 4.5mg/ml Glucose
1µL 1.5mMATP
Procedure
Assemble a flow cell with slide glass, nitrocellulose coated cover glass, and double adhesive
tape.
1. Add 8µL of HMM to the flow cell and incubate for 5min
2. Block with 25µL of BSA and incubate for 5min. (capillary action and using kimwipe to
introduce the solution)
3. Wash with 25µL of Assay buffer.
4. Add 25uL of F-actin labeled with Rhodamine phalloidin solution.
5. Observe under the fluorescent microscope. Add 25µL of ATP solution. Non-binding
Actin will be washed off, and Binding actin will start to move.
6. Adjust the sensitivity of CCD camera and the intensity of fluorescent. (Rhodamine will
be fluoresced under the green light)
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Table 1.TMCS UV/Ozone exposure Vs contact angle.
Contact angle (θ)
CA
CA
CA
CA
CA
CA
CA
CA
N
Mean
Standard Deviation
Standard Error of the mean
Relative Expression Level
Standard error of the mean
% RE
SE

0 min
83
85.8
85
83
87.8
85
88
87
8
84.60
42.32
15.99
1.00
0.19
100.00
18.91
0.00

0.5 min
70.5
69
65.9
66.9
70
68.4
67
70.5
8
68.47
34.29
12.96
0.81
0.15
80.93
15.32
0.50

1 min
60
57.4
60
64
62.2
54
54
57.6
8
59.13
29.59
11.18
0.70
0.13
69.90
13.22
1.00

2 min
37.7
49
54
52
45
34.9
46.9
40.7
8
46.90
24.42
9.23
0.55
0.11
55.44
10.91
2.00

5 min
23.7
29.2
20.2
32
29
26.9
29.8
22.8
8
24.37
12.73
4.81
0.29
0.06
28.80
5.69
5.00

10 min
21.8
19.7
22.8
31.9
16
21.3
16
17.8
8
21.43
10.79
4.08
0.25
0.05
25.33
4.82
10.00
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Table 2. Fluorescence intensity Vs TMCS UV/Ozone exposure time.

IDV
IDV
IDV
IDV
IDV
IDV
N
Mean
SD
SEM
relative expression level
SEM
%RE
SE

0 min
118.46
116.87
115.05
148.22
156.24
156.77
6.00
135.27
20.49
9.16
0.00
1.00
0.07
0.00

0.5 min
107.04
104.04
99.76
152.27
123.99
128.27
6.00
119.23
19.77
8.84
30.00
0.88
0.07
30.00
88.14
6.54

1min
75.39
77.07
77.07
100.99
95.49
95.49
6.00
86.92
11.59
5.18
60.00
0.64
0.04
60.00
64.26
3.83

2min
42.76
41.25
42.69
97.96
94.20
84.05
6.00
67.15
27.68
12.38
120.00
0.50
0.09
120.00
49.64
9.15

5min
31.40
32.72
32.83
87.06
78.39
74.11
6.00
56.08
26.38
11.80
300.00
0.41
0.09
300.00
41.46
8.72

10min
29.97
31.35
29.83
29.93
39.96
42.74
6.00
33.96
5.81
2.60
600.00
0.25
0.02
600.00
25.11
1.92
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Table 3. Average velocity of F-Actin (µm/sec) on nitrocellulose and TMCS.
Nitrocellulose
(Collodion)

N
Mean
Standard Deviation
Standard Error of the
mean
Max
Min
Total

TMCS
Actual
Velocity
µm/sec
60µg/ml
1.03
0.89
0.78

Actual Velocity
µm/sec
60µg/ml
1.27
1.17
0.97

90µg/ml
1.07
1.17
1.03

120µg/ml
1.75
1.52
1.47

1.03
0.98
1.20
0.83
1.06
1.40

1.17
1.03
1.02
1.19
1.03
1.12

1.52
1.34
1.39
1.23
1.03
1.79

1.06
1.13
1.27
1.30
1.31
1.22

1.03
1.08
1.13
1.15
1.05
1.09

1.86
1.50
1.88
1.81
1.86
1.90

1.19
16.00
1.15
0.15

1.02
16.00
1.09
0.06

1.82
16.00
1.60
0.27

7.00
1.11
0.26

11.00
1.32
0.14

1.26
16.00
1.56
0.18

0.04
1.40
0.83
18.37

0.02
1.19
1.02
17.39

0.07
1.90
1.03
25.67

0.11
1.52
0.78
7.79

0.04
1.57
1.16
14.52

0.05
1.94
1.25
24.97

0.99
1.52
1.31
1.26

90µg/ml
1.16
1.26
1.29

120µg/ml
1.32
1.45
1.61

1.57
1.27
1.56
1.23
1.16
1.34

1.72
1.64
1.53
1.52
1.70
1.94

1.41
1.29

1.52
1.73
1.69
1.25
1.51
1.57
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Statistical Analysis:
One Way Analysis of Variance

Friday, July 11, 2008, 11:50:42 AM

Data source: Contact angle Measurements VS Time of Exposure to UV on TMCS
Normality Test:

Passed (P = 0.133)

Equal Variance Test:

Failed

(P < 0.050)

Test execution ended by user request, ANOVA on Ranks begun
Kruskal-Wallis One Way Analysis of Variance on Ranks

Friday, July 11, 2008, 11:50:42 AM

Data source: Data 1 in Notebook 1
Group
0 min
0.5 min
1 min
2 min
5 min
10 min

N
8
8
8
8
8
8

Missing
0
0
0
0
0
0

Median
85.400
68.700
58.800
45.950
27.950
20.500

25%
84.000
66.950
55.700
39.200
23.250
16.900

75%
87.400
70.250
61.100
50.500
29.500
22.300

H = 44.942 with 5 degrees of freedom. (P = <0.001)
The differences in the median values among the treatment groups are greater than would be expected by chance;
there is a statistically significant difference (P = <0.001)
To isolate the group or groups that differ from the others use a multiple comparison procedure.
All Pairwise Multiple Comparison Procedures (Tukey Test):
Comparison
0 min vs 10 min
0 min vs 5 min
0 min vs 2 min
0 min vs 1 min
0 min vs 0.5 min
0.5 min vs 10 min
0.5 min vs 5 min
0.5 min vs 2 min
0.5 min vs 1 min
1 min vs 10 min
1 min vs 5 min
1 min vs 2 min
2 min vs 10 min
2 min vs 5 min
5 min vs 10 min

Diff of Ranks
309.500
266.500
191.000
129.000
64.000
245.500
202.500
127.000
65.000
180.500
137.500
62.000
118.500
75.500
43.000

q
7.816
6.730
4.823
3.258
1.616
6.200
5.114
3.207
1.641
4.558
3.472
1.566
2.993
1.907
1.086

P<0.05
Yes
Yes
Yes
No
Do Not Test
Yes
Yes
No
Do Not Test
Yes
No
Do Not Test
No
Do Not Test
Do Not Test
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Note: The multiple comparisons on ranks do not include an adjustment for ties.
A result of "Do Not Test" occurs for a comparison when no significant difference is found between the two rank
sums that enclose that comparison. For example, if you had four rank sums sorted in order, and found no significant
difference between rank sums 4 vs. 2, then you would not test 4 vs. 3 and 3 vs. 2, but still test 4 vs. 1 and 3 vs. 1 (4
vs. 3 and 3 vs. 2 are enclosed by 4 vs. 2: 4 3 2 1). Note that not testing the enclosed rank sums is a procedural rule,
and a result of Do Not Test should be treated as if there is no significant difference between the rank sums, even
though one may appear to exist.

One Way Analysis of Variance

Friday, July 11, 2008, 11:55:25 AM

Data source: Florescence intensity VS Time of Exposure to UV
Normality Test:
Passed (P = 0.397)
Equal Variance Test:

Failed

(P < 0.050)

Test execution ended by user request, ANOVA on Ranks begun
Kruskal-Wallis One Way Analysis of Variance on Ranks

Friday, July 11, 2008, 11:55:25 AM

Data source: Data 1 in Contact angles Sigma stat-1.SNB
Group
0 min
0.5 min
1min
2min
5min
10min

N
6
6
6
6
6
6

Missing
0
0
0
0
0
0

Median
133.342
115.518
86.280
63.401
53.469
30.663

25%
116.866
104.039
77.072
42.694
32.716
29.929

75%
156.241
128.268
95.488
94.199
78.386
39.963

H = 29.128 with 5 degrees of freedom. (P = <0.001)
The differences in the median values among the treatment groups are greater than would be expected by chance;
there is a statistically significant difference (P = <0.001)
To isolate the group or groups that differ from the others use a multiple comparison procedure.
All Pairwise Multiple Comparison Procedures (Tukey Test):
Comparison
0 min vs 10min
0 min vs 5min
0 min vs 2min
0 min vs 1min
0 min vs 0.5 min
0.5 min vs 10min
0.5 min vs 5min
0.5 min vs 2min

Diff of Ranks
162.000
124.000
99.000
78.000
17.000
145.000
107.000
82.000

q
6.277
4.805
3.836
3.022
0.659
5.619
4.146
3.177

P<0.05
Yes
Yes
No
Do Not Test
Do Not Test
Yes
Yes
Do Not Test
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0.5 min vs 1min
1min vs 10min
1min vs 5min
1min vs 2min
2min vs 10min
2min vs 5min
5min vs 10min

61.000
84.000
46.000
21.000
63.000
25.000
38.000

2.364
3.255
1.782
0.814
2.441
0.969
1.472

Do Not Test
No
Do Not Test
Do Not Test
Do Not Test
Do Not Test
Do Not Test

Note: The multiple comparisons on ranks do not include an adjustment for ties.
A result of "Do Not Test" occurs for a comparison when no significant difference is found between the two rank
sums that enclose that comparison. For example, if you had four rank sums sorted in order, and found no significant
difference between rank sums 4 vs. 2, then you would not test 4 vs. 3 and 3 vs. 2, but still test 4 vs. 1 and 3 vs. 1 (4
vs. 3 and 3 vs. 2 are enclosed by 4 vs. 2: 4 3 2 1). Note that not testing the enclosed rank sums is a procedural rule,
and a result of Do Not Test should be treated as if there is no significant difference between the rank sums, even
though one may appear to exist.

Two Way Analysis of Variance

Saturday, August 04, 2007, 7:20:25 PM

Data source: Data 1 in AnalysisVelocity(TMCS.Nitrocellulose).070804A
General Linear Model
Dependent Variable: Velocity
Normality Test:

Passed (P = 0.289)

Equal Variance Test:

Failed

Source of Variation
Substrates
HMM
Substrates x HMM
Residual
Total

DF
1
2
2
76
81

(P < 0.050)
SS
0.0499
3.223
0.324
2.578
6.440

MS
0.0499
1.611
0.162
0.0339
0.0795

F
1.470
47.506
4.782

P
0.229
<0.001
0.011

Main effects cannot be properly interpreted if significant interaction is determined. This is because the size of a
factor's effect depends upon the level of the other factor.
The effect of different levels of Substrates depends on what level of HMM is present. There is a statistically
significant interaction between Substrates and HMM. (P = 0.011)
Power of performed test with alpha = 0.0500: for Substrates : 0.0972
Power of performed test with alpha = 0.0500: for HMM : 1.000
Power of performed test with alpha = 0.0500: for Substrates x HMM : 0.673
Least square means for Substrates :
Group
Mean
SEM
Collodion
1.280
0.0266
TMCS
1.331
0.0334
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Least square means for HMM :
Group
Mean
SEM
60ug/ml
1.131
0.0417
90ug/ml
1.204
0.0361
120ug/ml 1.583
0.0326
Least square means for Substrates x HMM :
Group
Mean
SEM
Collodion x 60ug/ml
1.148
0.0460
Collodion x 90ug/ml
1.087
0.0460
Collodion x 120ug/ml
1.604
0.0460
TMCS x 60ug/ml
1.113
0.0696
TMCS x 90ug/ml
1.320
0.0555
TMCS x 120ug/ml
1.561
0.0460

All Pairwise Multiple Comparison Procedures (Tukey Test):
Comparisons for factor: Substrates
Comparison
Diff of Means
TMCS vs. Collodion
0.0518
Comparisons for factor: HMM
Comparison
Diff of Means
120ug/ml vs. 60ug/ml
0.452
120ug/ml vs. 90ug/ml
0.379
90ug/ml vs. 60ug/ml
0.0729

p
2

q
1.715

p
3
3
3

P
0.229

P<0.050
No

q
12.077
11.033
1.870

P
<0.001
<0.001
0.387

P<0.050
Yes
Yes
No

Comparisons for factor: HMM within Collodion
Comparison
Diff of Means
p
120ug/ml vs. 90ug/ml
0.517
3
120ug/ml vs. 60ug/ml
0.456
3
60ug/ml vs. 90ug/ml
0.0613
3

q
11.239
9.907
1.332

P
<0.001
<0.001
0.616

P<0.05
Yes
Yes
No

Comparisons for factor: HMM within TMCS
Comparison
Diff of Means
p
120ug/ml vs. 60ug/ml
0.448
3
120ug/ml vs. 90ug/ml
0.241
3
90ug/ml vs. 60ug/ml
0.207
3

q
7.588
4.717
3.291

P
<0.001
0.004
0.058

P<0.05
Yes
Yes
No

Comparisons for factor: Substrates within 60ug/ml
Comparison
Diff of Means
p
q
Collodion vs. TMCS
0.0350
2
0.593

P
0.677

P<0.05
No

Comparisons for factor: Substrates within 90ug/ml
Comparison
Diff of Means
p
q
TMCS vs. Collodion
0.234
2
4.579

P
0.002

P<0.05
Yes
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Comparisons for factor: Substrates within 120ug/ml
Comparison
Diff of Means
p
q
Collodion vs. TMCS
0.0433
2
0.941

P
0.508

P<0.05
No
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